Glycosyl compounds
Medchemexpress LLC VEGF-D Human CHO 10ug
VEGF-D Protein Human (CHO) is a regulator of both angiogenesis and lymphangiogenesis
Sigma Aldrich Fine Chemicals Biosciences 5-Bromo-4-chloro-3-indolyl alpha-D-galactopyranoside >=98.0% (HPLC) | 107021-38-5 | MFCD00063780 | 100MG
5-Bromo-4-chloro-3-indolyl alpha-D-galactopyranoside >=98.0% (HPLC) | Purity: >=98.0% (HPLC) | Mol Wt: 408.63 | 107021-38-5 | MFCD00063780 | 100MG
Medchemexpress LLC 5-nitro-6-(3-nitrophenyl)-2-oxo-4-(trifluoromethyl)-1H-pyridine-3-carbonitrile | 685121-45-3 | MFCD04111032; MFCD31735118; MFCD32015709 | 99.9% | 354.20 g/mol | C13H5F3N4O5 | 10MM 1ML
SynuClean-D is a small-molecule inhibitor of α-synuclein aggregation used in research to disrupt amyloid fibrils and inhibit fibril propagation; it has shown neuroprotective effects in Parkinson's disease models.
- Inhibits α-synuclein aggregation in vitro.
- Disrupts mature amyloid fibrils.
- Prevents fibril propagation and seeding.
- Reduces dopaminergic neuron degeneration in animal models.
- Available as a 10 mM solution in DMSO and in multiple solid quantities.
- High assay purity (≈99.9%).
- Molecular formula C13H5F3N4O5, molecular weight 354.20 g/mol.
Medchemexpress LLC Swertiamarin | 17388-39-5 | MFCD07783984 | 98.0% | 374.34 g·mol⁻¹ | C16H22O10 | 10 MG
Swertiamarin is an iridoid glycoside (C16H22O10, MW 374.34 g·mol⁻¹) reported to have hypoglycemic, hypolipidemic, anti-rheumatic, and antioxidant activities. Supplied as an analytical standard for laboratory research, it is used for qualitative and quantitative analyses by HPLC, GC, and MS and is intended for research use only.
- Suitable for qualitative and quantitative analysis by HPLC, GC, and MS.
- Reported orally active iridoid with hypoglycemic and antioxidant activity.
- Provided in small solid quantities appropriate for analytical workflows.
- Molecular weight 374.34 g·mol⁻¹; chemical formula C16H22O10.
- Purity commonly specified as 98% by HPLC; see Certificate of Analysis for details.
Medchemexpress LLC 2-O-α-D-Glucopyranosyl-L-ascorbic Acid | 129499-78-1 | 1 ML
2-O-α-D-Glucopyranosyl-L-ascorbic Acid is an orally active glucoside derivative of ascorbic acid. It can be hydrolyzed by α-glucosidase to release ascorbic acid. This compound inhibits melanin synthesis, prevents UV-induced cell damage, promotes collagen synthesis in skin fibroblasts, and induces oxidative stress to inhibit tumor growth. It is suitable for research related to tumors, inflammation, and other conditions.
- Orally active glucoside derivative
- Hydrolyzed by α-glucosidase to release ascorbic acid
- Inhibits melanin synthesis
- Prevents UV-induced cell damage
- Promotes collagen synthesis in skin fibroblasts
- Induces oxidative stress to inhibit tumor growth
- Used in research for tumors, inflammation, and other conditions
Medchemexpress LLC D-Sedoheptulose-7-phosphate barium | 17187-72-3 | 99.70% | 427.49 | 1 MG
D-Sedoheptulose-7-phosphate barium is a common precursor for the heptoses of septacidin (group III) and hygromycin B (group IV). It can be converted to NDP-heptoses through similar biosynthetic pathways in those compounds.
- Common precursor for heptoses of septacidin (group III) and hygromycin B (group IV)
- Converts to NDP-heptoses through similar biosynthetic pathways